Immune Design CS
(IMDZ)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2013 | 12-2012 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 30,387 | 12,762 |
| Receivables | 87 | 513 |
| Inventories | 17 | 252 |
| TOTAL | $30,670 | $13,714 |
| Non-Current Assets | ||
| PPE Net | 295 | 538 |
| TOTAL | $295 | $538 |
| Total Assets | $30,965 | $14,252 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 866 | 1,079 |
| Accrued Expenses | 1,082 | 1,535 |
| TOTAL | $1,975 | $2,646 |
| Non-Current Liabilities | ||
| Deferred Revenues | 27 | 32 |
| Other Non-Current Liabilities | 3,336 | 0 |
| TOTAL | $3,430 | $N/A |
| Total Liabilities | $5,405 | $2,646 |
| Shareholders' Equity | ||
| Common Shares | 3 | 3 |
| Retained earnings | -56,612 | -40,637 |
| Other shareholders' equity | 81,394 | 51,726 |
| TOTAL | $25,560 | $11,606 |
| Total Liabilities And Equity | $30,965 | $14,252 |